For hospital leaders who refuse to accept that surgical site infection is an inevitable outcome in patients undergoing high risk abdominal surgery...

CleanCisionTM

A novel, first-in-class, advanced intraoperative infection control system, developed by surgeons and infection control experts, to attack and defend against the most pervasive sources of surgical site infection. 

Utilizing innovative active cleansing technology, CleanCision combines wound protection and irrigation into an easy-to-use retraction system that actively, consistently, and continuously clears harmful bacteria that may invade the incision during surgery. 

More Control over Sources of Surgical Site Infection

Readily incorporated into surgical and infection reduction protocols, only CleanCision has been shown to reverse pre-existing contamination1, fight and remove intraoperative contamination1 and suppress bacterial proliferationafter incision closure.

Find out more about how reducing SSIs with CleanCision can enhance your hospital’s surgical site infection control bundles and result in significant cost savings.

FDA 510(k) Clearance

The U.S. Food and Drug Administration (FDA) has cleared the CleanCision™ Wound Retraction and Protection System (CleanCision™ System) for commercialization in the United  States. Read More.

2017 Prescient Surgical

1585 Industrial Rd. 
San Carlos, CA 94070

CleanCision in use
Submit

Call
T: (650) 999-0263

Based in San Carlos, Calif., Prescient Surgical, Inc. is a medical device innovator that makes advanced tools and technologies to fight and defend against the sources of surgical site infection. With technological innovation, greater awareness, and ongoing collaboration with hospitals around best practices, Prescient Surgical is dedicated to making surgery safer, improving the patient experience with surgery, and significantly improving post-operative outcomes. The company was conceived at the Stanford Byers Center for Biodesign and accelerated at Stanford StartX Med and the Fogarty Institute for Innovation.

References

1 Papaconstantinou HT, Ricciardi R, Margolin DA, et al. A Novel Surgical Device Combining Continuous Intraoperative Wound Irrigation and Barrier Protection Markedly Reduces Incisional Contamination in Colorectal Surgery. Oral presentation at: American Society of Colon and Rectal Surgeons Annual Scientific Meeting; June 2017; Seattle, WA.

2 Suh I, Long SA, Coe J, Koehler J, Fry D, Welton ML. The Efficacy of a Novel Surgical Device in Preventing Intraoperative Wound Contamination in an In Vivo Porcine Model. J Laparoendosc Adv Surg Tech A. 2017

3 As shown in: Papaconstantinou HT, Ricciardi R, Margolin D, et al. Impact of Novel Wound Protection Device on Observed vs. Expected Surgical Site Infection Rates Following Colectomy Using the National Surgical Quality Improvement Program Risk Calculator. Paper presented at: WSA 2017 Annual Meeting 2017; Scottsdale, AZ.

Fix the following errors:
Hide